BIM
INSY

BlackRock Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

BlackRock Investment Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.05M Sell
113,808
-5,476
-5% -$61.9K ﹤0.01% 2671
2016
Q3 		$1.41M Buy
119,284
+5,351
+5% +$81.3K ﹤0.01% 2443
2016
Q2 		$1.47M Buy
113,933
+9,406
+9% +$137K ﹤0.01% 2353
2016
Q1 		$1.67M Sell
104,527
-17,846
-15% -$339K ﹤0.01% 2120
2015
Q4 		$3.5M Buy
122,373
+44,032
+56% +$1.22M ﹤0.01% 1652
2015
Q3 		$2.23M Sell
78,341
-1,747
-2% -$64.3K ﹤0.01% 2000
2015
Q2 		$2.88M Buy
80,088
+21,676
+37% +$675K ﹤0.01% 1942
2015
Q1 		$1.7M Buy
58,412
+796
+1% +$21.1K ﹤0.01% 2153
2014
Q4 		$1.22M Sell
57,616
-288
-0.5% -$5.7K ﹤0.01% 2412
2014
Q3 		$1.12M Sell
57,904
-94,670
-62% -$1.49M ﹤0.01% 2446
2014
Q2 		$2.38M Buy
152,574
+69,238
+83% +$1.12M ﹤0.01% 1947
2014
Q1 		$1.73M Sell
83,336
-95,881
-53% -$1.9M ﹤0.01% 2138
2013
Q4 		$2.31M Buy
179,217
+136,011
+315% +$1.89M ﹤0.01% 1926
2013
Q3 		$504K Buy
43,206
+3,723
+9% +$30.6K ﹤0.01% 2928
2013
Q2 		$182K Buy
+39,483
New +$145K ﹤0.01% 3176

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Investment Management's INSY Position: Q4 2016 in Review

BlackRock Investment Management reduced its Insys Therapeutics, Inc. (INSY) stake by 4.6% in Q4 2016, selling an estimated $61.9K and leaving 113,808 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

BlackRock Investment Management first reported a position in INSY in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.5M in Q4 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • BlackRock Investment Management held 113,808 shares of Insys Therapeutics, Inc. worth $1.05M as of Q4 2016.
  • BlackRock Investment Management sold 5,476 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $61.9K.
  • Insys Therapeutics, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2671 holding.
  • BlackRock Investment Management first reported a position in Insys Therapeutics, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Insys Therapeutics, Inc. position peaked at $3.5M in Q4 2015.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.